House
GuidelinesCalculatorsPricingBlog
Ask House ↗
Guidelines↗Calculators↗Pricing↗Blog↗
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House
Back to guidelines
Dentistry · Cardiology

Prophylaxis against infective endocarditis

NICE · 2016 edition / updateSource checked 29 October 2026
Read the source publication
House clinical summary

Scope

NICE CG64 addresses prevention of infective endocarditis in adults and children undergoing specified interventional procedures. It combines recognition of increased cardiac risk with patient advice, a non-routine prophylaxis policy and prompt management of infection.

Written by House with AI assistance · AI-assisted source check 29 October 2026.

This is House’s summary of the cited guidance. The source check is not an independent clinician review. Open the publication for complete recommendations, exceptions, evidence grades and later amendments.

Recognize increased cardiac risk

  • Regard acquired valvular disease with stenosis or regurgitation, hypertrophic cardiomyopathy, previous endocarditis and valve replacement as conditions associated with increased risk of infective endocarditis. [1]
  • Structural congenital heart disease, including surgically corrected or palliated conditions, is included in the increased-risk group. The stated exceptions are isolated atrial septal defect, fully repaired ventricular septal defect or patent ductus arteriosus, and closure devices judged to be endothelialised. [1]

Explain prevention and warning symptoms

  • Give consistent advice about the benefits and risks of antibiotic prophylaxis and why it is no longer routinely recommended. Emphasize good oral health and explain symptoms that may indicate endocarditis and when expert advice is needed. [1]
  • Discuss the risks of invasive procedures, including non-medical procedures such as body piercing and tattooing. [1]

Apply the stated prophylaxis policy

  • Antibiotic prophylaxis against endocarditis is not recommended routinely for dental procedures. For patients at high risk undergoing dental work, consult the Scottish Dental Clinical Effectiveness Programme implementation advice referenced by NICE; the recommendation should not be restated as an absolute prohibition. [1]
  • Prophylaxis is also not recommended routinely for the specified non-dental procedures: upper or lower gastrointestinal procedures; genitourinary procedures, including urological, gynaecological and obstetric procedures and childbirth; and upper or lower respiratory procedures, including ENT procedures and bronchoscopy. [1]
  • Do not offer chlorhexidine mouthwash to prevent endocarditis in at-risk people undergoing dental procedures. [1]

Treat infection promptly

  • Investigate and treat infection promptly in people at risk of endocarditis, to reduce the chance of endocarditis developing. [1]
  • If an at-risk patient is already receiving antimicrobial therapy because a gastrointestinal or genitourinary procedure is being performed at a site of suspected infection, the antibiotic should cover organisms that cause endocarditis. [1]

Limitations and use

  • This is NICE guidance, including its specific UK implementation reference for high-risk dental patients. The non-dental procedural evidence covers only the listed gastrointestinal, genitourinary and respiratory sites. Other procedural sites and detailed prophylactic drug regimens are not established here.

This summary is selective and does not reproduce every recommendation. Apply the source’s population, setting and eligibility criteria, together with clinical judgement and local policy.

Summary sources

  1. 1
    Prophylaxis against infective endocarditis

    Guideline recommendation text consulted

Clinical guideline

Publication details

Issuing organisation
NICE
First published
17 March 2008
Publisher’s latest update
8 July 2016
Resource type
Clinical guideline · House clinical summary

Earlier House summaries: infective endocarditis prevention nice

The source check confirms publication details and the linked edition. It does not certify every recommendation or its suitability for an individual patient. Publisher access conditions may apply.

On this page

  • Scope
  • Recognize increased cardiac risk
  • Explain prevention and warning symptoms
  • Apply the stated prophylaxis policy
  • Treat infection promptly
  • Limitations and use
  • Summary sources
  • Publication details
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House